All news

Better Healthcare ETF: Fidelity's Broad, Low-Cost FHLC vs. State Street's XBI Targeting Biotech

Alpha Vantage · The Motley Fool · · AI-summarised by FinFlash

This article compares two healthcare exchange-traded funds (ETFs): Fidelity's FHLC, which offers broad, low-cost exposure to the entire healthcare sector, and State Street's XBI, which focuses more narrowly on biotechnology. FHLC is presented as a more conservative option with a lower expense ratio and higher dividend yield, while XBI offers higher potential returns but also greater volatility due to its biotech focus. The choice between the two depends on an investor's risk tolerance and desired exposure to the healthcare industry.

Read original source

LLY company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.